Search results
Small-Molecule Price Controls Are Short-Sighted
Forbes· 5 days agoThe combination of smoking reduction, increased screening, and pharmaceutical advancements has caused the lung cancer death rate to drop 20% over the...
MARKET REPORT: Nvidia shares recover after $577bn sell-off
This Is Money· 4 days agoShares in artificial intelligence chip designer Nvidia rose nearly 6 per cent after a three-day rout...
6 Top Weight Loss Stocks To Buy Now
Forbes· 2 days agoDiscover the top weight loss stocks to buy now. Find the top companies leading the health and wellness industry for potentially high returns and...
London midday: Stocks fall as Rolls-Royce, Melrose hit by Airbus warning
ShareCast· 4 days agoLondon stocks had fallen into the red by midday on Tuesday, with Rolls-Royce and Melrose pacing the...
3 Healthcare Mutual Funds Thriving Amid Economic Shifts
Zacks via Yahoo Finance UK· 3 days agoHealthcare mutual funds such as FPHAX, VGHCX and PHSTX are increasingly favored as solid investments...
US Supreme Court gives pharma companies a chance to thwart terrorism-funding lawsuit
Reuters· 5 days ago, opens new tab to a lawsuit accusing them of illegally helping to fund terrorism that killed or...
FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
Zacks via Yahoo Finance UK· 3 days agoThe FDA grants priority review to Ionis' (IONS) filing seeking approval for olezarsen to treat...
Your Voice, Your Vote: 'We need Covid drug Evusheld on the NHS'
BBC News· 1 day agoThe impact of Covid-19 on immunocompromised people is of major concern for an East Yorkshire...
London close: Stocks mixed ahead of key UK, US data
ShareCast· 2 days agoLondon stocks ended Thursday's trading session with a mixed performance as market participants awaited crucial US inflation data and UK GDP figures set...
Nearly £5bn wiped off value of GSK as US restricts RSV vaccine jabs
This Is Money· 2 days agoNearly £5billion was wiped off the value of GSK after a top US health agency limited the scope of its blockbuster respiratory vaccine. In a further setback for the UK pharmaceutical giant, the ...